Skip to main content

Table 1 Association between selective and universal offer of an oral glucose tolerance test (OGTT) with gestational diabetes and severe hyperglycaemia detection rate (number tested with percentage of whole population and percentage of screened population in parenthesis)

From: Evaluation of the impact of universal testing for gestational diabetes mellitus on maternal and neonatal health outcomes: a retrospective analysis

 

Selective offering of an OGTT

Universal offering of an OGTT

 
 

2004

2005

2006

2004-2006

2008

2009

2010

2008-2010

Rate ratio comparing detection rates after to before (95% CI) for the whole population and for the screened population

Whole population

5512

5784

5864

17160

6162

6251

6101

18514

 

Completed OGTT

323 (6)

299 (5)

529 (9)

1151 (7)

3797 (62)

3947 (63)

3772 (62)

11516 (62)

 

GDMa identified

62 (1, 19)

83 (1, 28)

135 (2, 26)

280 (2, 24)

311 (5, 8)

398 (6, 10)

423 (7, 11)

1132 (6, 10)

3.75 (3.28 - 4.29) 0.40 (0.35 - 0.46)

Severe hyperglycaemiab identified

21 (0.4, 34)

33 (0.6, 40)

29 (0.5, 21)

83 (0.5, 30)

46 (0.7, 14)

63 (1.0, 16)

63 (1.0, 16)

172 (1.0, 15)

1.96 (1.50 - 2.58) 0.51 (0.39 - 0.67)

  1. OGTT = oral glucose tolerance test.
  2. GDM = gestational diabetes mellitus, CI = confidence interval.
  3. aGDM = either a fasting blood glucose ≥6.1 mmol/L, or a two hour blood glucose ≥7.8 mol/L or both.
  4. bSevere hyperglycaemia = either a fasting blood glucose ≥7 mmol/L, or a two hour blood glucose ≥11.1 mmol/L or both.